Cholesterol esterification reduces the neurotoxicity of prions

Bate, C; Tayebi, M; Williams, A

Abstract

The transmissible spongiform encephalopathies develop following the conversion of a host-encoded protein (PrPC) into abnormally folded, disease-related isoforms (PrPSc). Here we report that three acylcoenzyme A:cholesterol acyltransferase (ACAT) inhibitors, TMP-153, FR179254 or YIC-C8-434, were more toxic to prion-infected neuronal cell lines (ScGT1 and ScN2a cells) than to their uninfected equivalents (GT1 and N2a cells). The toxicity of ACAT inhibitors for ScGT1 cells was not reversed by the addition of cholesterol esters, rather it was increased by the addition of free cholesterol indicating that the toxicity of ACAT inhibitors was related to the increased free cholesterol content of cells rather than reduced amounts of cholesterol esters. This hypothesis was strengthened by the observation that the addition of free cholesterol killed ScGT1, but not GT1 cells. Treatment with ACAT inhibitors increased caspase-3 activity and prostaglandin E-2 production in ScGT1 cells but not in GT1 cells. The addition of the phospholipase A(2) (PLA(2)) inhibitors (AACOCF(3) or MAFP) reduced prostaglandin E-2 productionand protected ScGT1 cells against the toxicity of ACAT inhibitors. These results indicate that cholesterol esterification is an important cellular response that reduces PrPSc-induced activation of PLA(2) and protects against cell death in ScGT1 cells. (c) 2008 Elsevier Ltd. All rights reserved.

Citation

Bate, C., Tayebi, M., & Williams, A. Cholesterol esterification reduces the neurotoxicity of prions. Neuropharmacology, 54(8), 1247-1253. https://doi.org/10.1016/j.neuropharm.2008.04.002

• Journal Article Type: Article
• Deposit Date: Nov 11, 2014
• Journal: NEUROPHARMACOLOGY
• Print ISSN: 0028-3908
• Publisher: Elsevier
• Volume: 54
• Issue: 8
• Pages: 1247-1253
• DOI: https://doi.org/10.1016/j.neuropharm.2008.04.002
• Public URL: https://rvc-repository.worktribe.com/output/1428498